Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Heart, Lung, and Blood Institute (NHLBI) )
ClinicalTrials.gov Identifier:
NCT00260689
First received: December 1, 2005
Last updated: August 31, 2016
Last verified: August 2016